Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
The Prostate
|
September 25, 2004
A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancer
Kamakshi Rao, Susan Goodin, Michael J Levitt, et al.
Pathology Oncology Research : POR
|
May 26, 2018
Atorvastatin and Caffeine in Combination Regulates Apoptosis, Migration, Invasion and Tumorspheres of Prostate Cancer Cells
Zhenshi Wang, Lanyue Zhang, Zheng Wan, et al.
Clinical Genitourinary Cancer
|
October 19, 2015
A Phase II Study of AT-101 to Overcome Bcl-2--Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer
Mark N Stein, Maha Hussain, Walter M Stadler, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
August 28, 2003
A phase I and pharmacologic study of the combination of marimastat and paclitaxel in patients with advanced malignancy
Deborah L Toppmeyer, Murugesan Gounder, Judie Much, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
February 26, 2003
Gemcitabine combined with sequential paclitaxel and carboplatin in patients with urothelial cancers and other advanced malignancies
Robert S DiPaola, Eric Rubin, Deb Toppmeyer, et al.
Journal of Clinical Pharmacology
|
November 5, 2002
Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases
Tianling Chen, James Berenson, Robert Vescio, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
January 6, 2022
Inhibitory effect of roburic acid in combination with docetaxel on human prostate cancer cells
Xiao Wang, Xu Xuetao, Mengshuo Wu, et al.
American Journal of Clinical Oncology
|
June 1, 2005
Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone
Celeste Lindley, Susan Goodin, Jeannine McCune, et al.
Antioxidants (Basel, Switzerland)
|
December 24, 2021
Essential Oils from <i>Zingiber striolatum</i> Diels Attenuate Inflammatory Response and Oxidative Stress through Regulation of MAPK and NF-κB Signaling Pathways
Zebin Huang, Lingna Xie, Yongyu Xu, et al.
Molecular Medicine Reports
|
January 28, 2015
α-Tomatine inhibits growth and induces apoptosis in HL-60 human myeloid leukemia cells
Huarong Huang, Shaohua Chen, Jeremiah Van Doren, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
The Prostate
|
September 25, 2004
A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancer
Kamakshi Rao, Susan Goodin, Michael J Levitt, et al.
Pathology Oncology Research : POR
|
May 26, 2018
Atorvastatin and Caffeine in Combination Regulates Apoptosis, Migration, Invasion and Tumorspheres of Prostate Cancer Cells
Zhenshi Wang, Lanyue Zhang, Zheng Wan, et al.
Clinical Genitourinary Cancer
|
October 19, 2015
A Phase II Study of AT-101 to Overcome Bcl-2--Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer
Mark N Stein, Maha Hussain, Walter M Stadler, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
August 28, 2003
A phase I and pharmacologic study of the combination of marimastat and paclitaxel in patients with advanced malignancy
Deborah L Toppmeyer, Murugesan Gounder, Judie Much, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
February 26, 2003
Gemcitabine combined with sequential paclitaxel and carboplatin in patients with urothelial cancers and other advanced malignancies
Robert S DiPaola, Eric Rubin, Deb Toppmeyer, et al.
Journal of Clinical Pharmacology
|
November 5, 2002
Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases
Tianling Chen, James Berenson, Robert Vescio, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
January 6, 2022
Inhibitory effect of roburic acid in combination with docetaxel on human prostate cancer cells
Xiao Wang, Xu Xuetao, Mengshuo Wu, et al.
American Journal of Clinical Oncology
|
June 1, 2005
Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone
Celeste Lindley, Susan Goodin, Jeannine McCune, et al.
Antioxidants (Basel, Switzerland)
|
December 24, 2021
Essential Oils from <i>Zingiber striolatum</i> Diels Attenuate Inflammatory Response and Oxidative Stress through Regulation of MAPK and NF-κB Signaling Pathways
Zebin Huang, Lingna Xie, Yongyu Xu, et al.
Molecular Medicine Reports
|
January 28, 2015
α-Tomatine inhibits growth and induces apoptosis in HL-60 human myeloid leukemia cells
Huarong Huang, Shaohua Chen, Jeremiah Van Doren, et al.
Page
of 8